Protective Role of the Interleukin 33 Rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients

Objectives: To determine whether the interleukin-33 (IL-33)-interleukin-1 receptor like 1 (IL-1RL1) signaling pathway is implicated in the risk of subclinical atherosclerosis in patients with rheumatoid arthritis (RA).

Methods: A total of 576 Spanish RA patients from Northern Spain were genotyped for 6 well-known IL33-IL1RL1 polymorphisms (IL33 rs3939286, IL33 rs7025417, IL33 rs7044343, IL1RL1 rs2058660, IL1RL1 rs2310173 and IL1RL1 rs13015714) by TaqMan genotyping assay. The presence of subclinical atherosclerosis was determined by the assessment of carotid intima-media thickness (cIMT) by carotid ultrasound (US).

Results: RA patients carrying the TT genotype of the IL33 rs3939286 polymorphism had lower cIMT values than those homozygous for the CC genotype (mean ± standard deviation (SD): 0.71 ± 0.14 mm versus 0.76 ± 0.16 mm, respectively) while patients carrying the CT genotype had intermediate cIMT values (mean ± SD: 0.73 ± 0.17 mm). Moreover, RA patients carrying the mutant allele T of the IL33 rs3939286 polymorphism exhibited significantly lower cIMT values than those carrying the wild allele C (mean ± SD: 0.72 ± 0.16 mm versus 0.75 ± 0.18 mm respectively; p = 0.04). The association of both genotype and allele frequencies of IL33 rs3939286 and cIMT levels remained statistically significant after adjustment for sex, age at the time of US study, follow-up and center (p = 0.006 and p = 0.0023, respectively), evidencing that the potential effect conferred by IL33 rs3939286 may be independent of confounder factors. No association with other IL33-IL1RL1 genetic variants was observed.

Conclusions: In conclusion, our results may suggest a potential protective effect of the IL33 rs3939286 allele T in the risk of subclinical atherosclerosis in patients with RA.

Citing Articles

Gene Polymorphisms of Epithelial Cell-Derived Alarmins and Their Effects on Protein Levels and Disease Severity in Patients with COVID-19.

Ranjbar M, Cusack R, Whetstone C, Nawaz S, Khoury C, Wattie J Genes (Basel). 2023; 14(9).

PMID: 37761861 PMC: 10530834. DOI: 10.3390/genes14091721.

Association of interleukin 33 gene polymorphisms with susceptibility and regulation of inflammatory mediators in Systemic lupus erythematosus patients.

Bagheri-Hosseinabadi Z, Mirzaei M, Aliakbari M, Abbasifard M Clin Rheumatol. 2023; 42(8):2187-2197.

PMID: 37067648 DOI: 10.1007/s10067-023-06575-y.

Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy.

Popescu D, Rezus E, Badescu M, Dima N, Seritean Isac P, Dragoi I Life (Basel). 2023; 13(2).

PMID: 36836675 PMC: 9965162. DOI: 10.3390/life13020319.

IL-33/ST2 immunobiology in coronary artery disease: A systematic review and meta-analysis.

Liu R, Liu L, Wei C, Li D Front Cardiovasc Med. 2022; 9:990007.

PMID: 36337880 PMC: 9630943. DOI: 10.3389/fcvm.2022.990007.

Inflammatory Mediators in Atherosclerotic Vascular Remodeling.

Evans B, Yerly A, van der Vorst E, Baumgartner I, Bernhard S, Schindewolf M Front Cardiovasc Med. 2022; 9:868934.

PMID: 35600479 PMC: 9114307. DOI: 10.3389/fcvm.2022.868934.

References

Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, Martin J, Gonzalez-Gay M . Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis. Arthritis Rheum. 2006; 55(1):150-3. DOI: 10.1002/art.21707. View

Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan T . IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005; 23(5):479-90. DOI: 10.1016/j.immuni.2005.09.015. View

Dessein P, Norton G, Woodiwiss A, Joffe B, Wolfe F . Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol. 2007; 34(5):943-51. View

Xu D, Jiang H, Kewin P, Li Y, Mu R, Fraser A . IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci U S A. 2008; 105(31):10913-8. PMC: 2491487. DOI: 10.1073/pnas.0801898105. View

Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay M . Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2008; 38(5):366-71. DOI: 10.1016/j.semarthrit.2008.01.012. View

Reveille J, Sims A, Danoy P, Evans D, Leo P, Pointon J . Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet. 2010; 42(2):123-7. PMC: 3224997. DOI: 10.1038/ng.513. View

Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham 3rd C . 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010; 69(9):1580-8. DOI: 10.1136/ard.2010.138461. View

Naredo E, Moller I, Gutierrez M, Bong D, Cobo T, Corominas H . Multi-examiner reliability of automated radio frequency-based ultrasound measurements of common carotid intima-media thickness in rheumatoid arthritis. Rheumatology (Oxford). 2011; 50(10):1860-4. DOI: 10.1093/rheumatology/ker206. View

Boyle A, Hong E, Hariharan M, Cheng Y, Schaub M, Kasowski M . Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012; 22(9):1790-7. PMC: 3431494. DOI: 10.1101/gr.137323.112. View

10.

Lopez-Mejias R, Garcia-Bermudez M, Gonzalez-Juanatey C, Castaneda S, Miranda-Filloy J, Gomez-Vaquero C . NFKB1-94ATTG ins/del polymorphism (rs28362491) is associated with cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis. 2012; 224(2):426-9. DOI: 10.1016/j.atherosclerosis.2012.06.008. View

11.

Latiano A, Palmieri O, Pastorelli L, Vecchi M, Pizarro T, Bossa F . Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease. PLoS One. 2013; 8(4):e62144. PMC: 3636262. DOI: 10.1371/journal.pone.0062144. View

12.

Corrales A, Parra J, Gonzalez-Juanatey C, Rueda-Gotor J, Blanco R, Llorca J . Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis. 2013; 72(11):1764-70. DOI: 10.1136/annrheumdis-2013-203688. View

13.

Tu X, Nie S, Liao Y, Zhang H, Fan Q, Xu C . The IL-33-ST2L pathway is associated with coronary artery disease in a Chinese Han population. Am J Hum Genet. 2013; 93(4):652-60. PMC: 3791271. DOI: 10.1016/j.ajhg.2013.08.009. View

14.

Guo L, Zhou X, Guo X, Zhang X, Sun Y . Association of interleukin-33 gene single nucleotide polymorphisms with ischemic stroke in north Chinese population. BMC Med Genet. 2013; 14:109. PMC: 3851730. DOI: 10.1186/1471-2350-14-109. View

15.

Lopez-Mejias R, Genre F, Garcia-Bermudez M, Corrales A, Gonzalez-Juanatey C, Llorca J . The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis. Arthritis Res Ther. 2013; 15(5):R152. PMC: 3978706. DOI: 10.1186/ar4335. View

16.

Li C, Mu R, Guo J, Wu X, Tu X, Liu X . Genetic variant in IL33 is associated with susceptibility to rheumatoid arthritis. Arthritis Res Ther. 2014; 16(2):R105. PMC: 4075243. DOI: 10.1186/ar4554. View

17.

Marquez A, Solans R, Hernandez-Rodriguez J, Cid M, Castaneda S, Ramentol M . A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCA. PLoS One. 2014; 9(11):e113476. PMC: 4237421. DOI: 10.1371/journal.pone.0113476. View

18.

Shen J, Shang Q, Wong C, Li E, Wang S, Li R . IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study. Semin Arthritis Rheum. 2015; 45(1):18-27. DOI: 10.1016/j.semarthrit.2015.02.001. View

19.

Gonzalez-Gay M, Gonzalez-Juanatey C, Martin J . Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum. 2005; 35(1):8-17. DOI: 10.1016/j.semarthrit.2005.03.004. View

20.

Gonzalez-Gay M, Gonzalez-Juanatey C, Lopez-Diaz M, Pineiro A, Garcia-Porrua C, Miranda-Filloy J . HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum. 2007; 57(1):125-32. DOI: 10.1002/art.22482. View